mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation (EVEROLD)

NCT01028092 Phase 3 COMPLETED

This study is designed to evaluate efficacity and safety of everolimus or (cyclosporine then everolimus) vs. cyclosporine as immunosuppressive treatment in renal transplantation for elderly (\>60 years old) recipients receiving graft from elderly donor(\>60 years old).

Details

Lead sponsor	University Hospital, Brest
Phase	Phase 3
Status	COMPLETED
Enrolment	327
Start date	2009-03
Completion	2014-07

Conditions

• Renal Transplant

Interventions

• Anti R-IL2 + Cyclosporine
• Thymoglobulin + Everolimus
• Anti R-IL2 + Cyclosporine then Everolimus

Primary outcomes

• calculated renal function with MDRD equation — 12 months

Countries

France